A Safety, Tolerability, and Efficacy Study of VX-880 in Participants With Type 1 Diabetes
NCT04786262
·
clinicaltrials.gov ↗
PHASE3
Phase
RECRUITING
Status
52
Enrollment
INDUSTRY
Sponsor class
Conditions
Diabetes Mellitus, Type 1
Impaired Hypoglycemic Awareness
Severe Hypoglycemia
Interventions
BIOLOGICAL:
VX-880
Sponsor
Vertex Pharmaceuticals Incorporated